| Role of trypsin and protease-activated receptor-2 in ovarian cancer KK Kim, R Turner, N Khazan, A Kodza, A Jones, RK Singh, RG Moore PLoS One 15 (5), e0232253, 2020 | 27 | 2020 |
| A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System EN Cohen, G Jayachandran, RG Moore, M Cristofanilli, JE Lang, ... Cancers 14 (21), 5238, 2022 | 26 | 2022 |
| HE4 overexpression by ovarian cancer promotes a suppressive tumor immune microenvironment and enhanced tumor and macrophage PD-L1 expression RB Rowswell-Turner, RK Singh, A Urh, N Yano, KK Kim, N Khazan, ... The Journal of Immunology 206 (10), 2478-2488, 2021 | 20 | 2021 |
| Development of potent forchlorfenuron analogs and their cytotoxic effect in cancer cell lines KK Kim, RK Singh, N Khazan, A Kodza, NA Singh, A Jones, ... Scientific Reports 10 (1), 3241, 2020 | 12 | 2020 |
| Analytical performance of the FDA-cleared Parsortix® PC1 system A Templeman, MC Miller, MJ Cooke, DJ O’shannessy, Y Gurung, ... Journal of Circulating Biomarkers 12, 26, 2023 | 10 | 2023 |
| Novel small molecule mek inhibitor urml-3881 enhances cisplatin sensitivity in clear cell ovarian cancer RB Rowswell-Turner, JA Rutishauser, KK Kim, N Khazan, ... Translational Oncology 12 (7), 917-924, 2019 | 7 | 2019 |
| Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors In Vivo N Khazan, KK Kim, JN Hansen, NA Singh, T Moore, CWA Snyder, ... Journal of medicinal chemistry 65 (8), 6039-6055, 2022 | 6 | 2022 |
| Septins disruption controls tumor growth and enhances efficacy of Herceptin RK Singh, KK Kim, N Khazan, RB Rowswell-Turner, C Laggner, A Jones, ... bioRxiv, 2020.02. 19.954529, 2020 | 4 | 2020 |
| Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1 N Khazan, ER Quarato, NA Singh, CWA Snyder, T Moore, JP Miller, ... Cancers 15 (13), 3432, 2023 | 3 | 2023 |
| Malignancy Assessment Using Gene Identification in Captured Cells Algorithm for the Prediction of Malignancy in Women With a Pelvic Mass RGMD Moore, NPD Khazan, MAMD Coulter, RPD Singh, MCBS Miller, ... Obstetrics & Gynecology, 2022 | 3 | 2022 |
| Targeting Vitamin-D receptor (VDR) by a small molecule antagonist MeTC7 inhibits PD-L1 but controls THMYCN neuroblastoma growth PD-L1 independently RK Singh, KK Kim, RB Rowswell-Turner, JN Hansen, N Khazan, A Jones, ... bioRxiv, 2020.08. 16.252940, 2020 | 3 | 2020 |
| Prognostic significance of circulating and disseminated tumor cells in breast cancer patients before and after adjuvant chemotherapy P Ghaffari, M Yousefi, M Aznab, N Khazan, M Yaghmaie, D Bashash, ... Cell Journal (Yakhteh) 26 (5), 293-308, 2024 | 1 | 2024 |
| MUC2 mRNA detection in peripheral blood and bone marrow of breast cancer patients reveals micrometastasis N Khazan, A Ghavamzadeh, AS Boyajyan, GM Mkrtchyan, ... Scientific Research Publishing, 2013 | 1 | 2013 |
| The Detection Of Micrometastases In Peripheral Blood And Bone Marrow Of Breast Cancer Patients Using Marker (MUC2) Real Time PCR. N Khazan, A Ghavamzadeh, A Boyajyan, G Mkrtchyan, K Alimoghaddam, ... Payavard Salamat 6 (2), 2012 | 1 | 2012 |
| Identification of circulating tumor cells captured by the FDA-cleared Parsortix® PC1 system from the peripheral blood of metastatic breast cancer patients using … M Ciccioli, K Kim, N Khazan, JD Khoury, MJ Cooke, MC Miller, ... Journal of Experimental & Clinical Cancer Research 43 (1), 240, 2024 | | 2024 |
| Forchlorfenuron-Induced Mitochondrial Respiration Inhibition and Metabolic Shifts in Endometrial Cancer Kim,Kyukwang,Khazan, Negar,Roswell-Turner,Rachael B, Singh,Rakesh K,Moore ... Cancers, 2024 | | 2024 |
| Ability of the novel MAGIC algorithm to predict progression free survival and overall survival in patients with pelvic malignancies (2270) L Marshall, K Kennedy, KK Kim, N Khazan, M Miller, R Moore Gynecologic Oncology 176, S297, 2023 | | 2023 |
| Utility of HE4 compared to CA125 as a prognostic indicator for progression free survival and overall survival in patients with EOC (1173) K Kennedy, L Marshall, K Kim, N Khazan, M Miller, R Moore Gynecologic Oncology 176, S119-S120, 2023 | | 2023 |
| Targeting HE4 for treatment of endometrial cancer using a novel small molecule inhibitor. A Morell, J Miller, N Zhang, C Snyder, N Khazan, MS Strawderman, ... Journal of Clinical Oncology 41 (16_suppl), e17616-e17616, 2023 | | 2023 |
| Abstract P1-05-35: Identification of Circulating Tumor Cells captured by the FDA Cleared Parsortix® PC1 System from the Peripheral Blood of Metastatic Breast Cancer Patients … M Ciccioli, R Moore, KK Kim, N Khazan, MC Miller, AS Pailhes-Jimenez Cancer Research 83 (5_Supplement), P1-05-35-P1-05-35, 2023 | | 2023 |
